Fig. 3
MR-proANP levels are not related to metabolic comorbidities a–b MR-proANP plasma concentrations in ICU patients are neither associated with pre-existing type 2 diabetes a nor obesity, as defined by a body-mass index (BMI) above 30 kg/m2b. c–d We observed significant correlations between MR-proANP and several adipocytokines including resistin (c) and adiponectin (d). p-values (U-test or Spearman rank correlation) are given